Thu, October 31, 2019
Wed, October 30, 2019
Tue, October 29, 2019

Mohit Bansal Maintained (BMRN) at Strong Buy with Decreased Target to $95 on, Oct 30th, 2019

Mohit Bansal of Citigroup, Maintained "BioMarin Pharmaceutical Inc." (BMRN) at Strong Buy with Decreased Target from $120 to $95 on, Oct 30th, 2019.

Mohit has made no other calls on BMRN in the last 4 months.



There are 3 other peers that have a rating on BMRN. Out of the 3 peers that are also analyzing BMRN, 1 agrees with Mohit's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Decreased Target to $86 on, Thursday, October 24th, 2019


These are the ratings of the 2 analyists that currently disagree with Mohit


  • Michelle Gilson of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $108 on, Monday, October 28th, 2019
  • Liana Moussatos of "Wedbush" Maintained at Buy with Increased Target to $152 on, Friday, October 25th, 2019